vs
Kodiak Gas Services, Inc.（KGS）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $332.9M、Kodiak Gas Services, Inc.の約1.5倍）。Kodiak Gas Services, Inc.の純利益率が高く（7.4% vs 6.8%、差は0.6%）。Kodiak Gas Services, Inc.の前年同期比売上増加率が高い（7.5% vs -1.7%）。過去8四半期でKodiak Gas Services, Inc.の売上複合成長率が高い（24.3% vs -0.1%）
コディアック・ガス・サービス社は北米を中心に事業を展開する天然ガス圧縮サービスの大手プロバイダーで、石油・ガス産業の上流・中流事業者向けに、カスタマイズされた圧縮装置、保守サポート、運用支援を提供し、陸上天然ガスの採取・処理・輸送の効率向上を支援している。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
KGS vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $332.9M | $493.8M |
| 純利益 | $24.6M | $33.7M |
| 粗利率 | — | — |
| 営業利益率 | 26.1% | 9.9% |
| 純利益率 | 7.4% | 6.8% |
| 売上前年比 | 7.5% | -1.7% |
| 純利益前年比 | 29.0% | 10.5% |
| EPS（希薄化後） | $0.30 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $332.9M | $493.8M | ||
| Q3 25 | $322.7M | $492.9M | ||
| Q2 25 | $322.8M | $468.8M | ||
| Q1 25 | $329.6M | $458.4M | ||
| Q4 24 | $309.5M | $502.4M | ||
| Q3 24 | $324.6M | $511.2M | ||
| Q2 24 | $309.7M | $504.3M | ||
| Q1 24 | $215.5M | $495.1M |
| Q4 25 | $24.6M | $33.7M | ||
| Q3 25 | $-14.0M | $71.7M | ||
| Q2 25 | $39.5M | $39.3M | ||
| Q1 25 | $30.4M | $20.7M | ||
| Q4 24 | $19.1M | $30.5M | ||
| Q3 24 | $-5.6M | $19.4M | ||
| Q2 24 | $6.2M | $-153.0M | ||
| Q1 24 | $30.2M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 37.5% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 39.4% | — |
| Q4 25 | 26.1% | 9.9% | ||
| Q3 25 | 19.9% | 13.8% | ||
| Q2 25 | 30.9% | 12.8% | ||
| Q1 25 | 27.1% | 7.0% | ||
| Q4 24 | 22.3% | 7.8% | ||
| Q3 24 | 20.4% | 6.6% | ||
| Q2 24 | 17.5% | -31.3% | ||
| Q1 24 | 27.9% | 3.2% |
| Q4 25 | 7.4% | 6.8% | ||
| Q3 25 | -4.3% | 14.5% | ||
| Q2 25 | 12.2% | 8.4% | ||
| Q1 25 | 9.2% | 4.5% | ||
| Q4 24 | 6.2% | 6.1% | ||
| Q3 24 | -1.7% | 3.8% | ||
| Q2 24 | 2.0% | -30.3% | ||
| Q1 24 | 14.0% | 0.8% |
| Q4 25 | $0.30 | $0.40 | ||
| Q3 25 | $-0.17 | $0.84 | ||
| Q2 25 | $0.43 | $0.46 | ||
| Q1 25 | $0.33 | $0.24 | ||
| Q4 24 | $0.18 | $0.37 | ||
| Q3 24 | $-0.07 | $0.23 | ||
| Q2 24 | $0.06 | $-1.84 | ||
| Q1 24 | $0.39 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $3.2M | $375.2M |
| 総負債低いほど良い | $2.6B | $570.5M |
| 株主資本純資産 | $1.2B | $865.9M |
| 総資産 | $4.3B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 2.12× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $3.2M | $375.2M | ||
| Q3 25 | $724.0K | $340.1M | ||
| Q2 25 | $5.4M | $224.7M | ||
| Q1 25 | $1.9M | $99.0M | ||
| Q4 24 | $4.8M | $229.9M | ||
| Q3 24 | $7.4M | $103.8M | ||
| Q2 24 | $3.9M | $19.4M | ||
| Q1 24 | $9.3M | $8.0M |
| Q4 25 | $2.6B | $570.5M | ||
| Q3 25 | $2.6B | $577.2M | ||
| Q2 25 | $2.5B | $583.9M | ||
| Q1 25 | $2.6B | $590.5M | ||
| Q4 24 | $2.6B | $597.1M | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $865.9M | ||
| Q3 25 | $1.3B | $890.7M | ||
| Q2 25 | $1.3B | $833.8M | ||
| Q1 25 | $1.4B | $789.2M | ||
| Q4 24 | $1.4B | $764.9M | ||
| Q3 24 | $1.4B | $732.5M | ||
| Q2 24 | $1.5B | $706.5M | ||
| Q1 24 | $1.1B | $856.2M |
| Q4 25 | $4.3B | $2.2B | ||
| Q3 25 | $4.4B | $2.2B | ||
| Q2 25 | $4.4B | $2.1B | ||
| Q1 25 | $4.4B | $2.0B | ||
| Q4 24 | $4.4B | $2.2B | ||
| Q3 24 | $4.5B | $2.1B | ||
| Q2 24 | $4.4B | $2.0B | ||
| Q1 24 | $3.3B | $2.2B |
| Q4 25 | 2.12× | 0.66× | ||
| Q3 25 | 2.08× | 0.65× | ||
| Q2 25 | 1.89× | 0.70× | ||
| Q1 25 | 1.91× | 0.75× | ||
| Q4 24 | 1.88× | 0.78× | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $194.9M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $142.0M | — |
| FCFマージンFCF / 売上 | 42.7% | — |
| 設備投資強度設備投資 / 売上 | 15.9% | — |
| キャッシュ転換率営業CF / 純利益 | 7.91× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $284.3M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $194.9M | $114.1M | ||
| Q3 25 | $113.4M | $137.3M | ||
| Q2 25 | $177.2M | $137.2M | ||
| Q1 25 | $114.3M | $-117.5M | ||
| Q4 24 | $118.5M | $133.0M | ||
| Q3 24 | $36.9M | $91.8M | ||
| Q2 24 | $121.1M | $107.0M | ||
| Q1 24 | $51.5M | $-125.2M |
| Q4 25 | $142.0M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $94.6M | — | ||
| Q1 25 | $36.8M | — | ||
| Q4 24 | $45.2M | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $-8.6M | — |
| Q4 25 | 42.7% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 29.3% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | -15.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -4.0% | — |
| Q4 25 | 15.9% | — | ||
| Q3 25 | 31.7% | — | ||
| Q2 25 | 25.6% | — | ||
| Q1 25 | 23.5% | — | ||
| Q4 24 | 23.7% | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 37.8% | — | ||
| Q1 24 | 27.9% | — |
| Q4 25 | 7.91× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 4.49× | 3.49× | ||
| Q1 25 | 3.76× | -5.66× | ||
| Q4 24 | 6.21× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | 19.44× | — | ||
| Q1 24 | 1.70× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
